DAVID B. SINGER - 17 Feb 2022 Form 4 Insider Report for CASTLIGHT HEALTH, INC.

Role
Director
Signature
/s/ Mary Ahern, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
4
Filing time
18 Feb 2022, 13:12:18 UTC
Previous filing
19 Jul 2021
Next filing
18 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSLT Class B Common Stock Disposed to Issuer -405,184 -100% 0 17 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSLT Director Stock Option (right to buy) Disposed to Issuer -25,000 -100% 0 17 Feb 2022 Class B Common Stock 25,000 $16.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

DAVID B. SINGER is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time.
F2 The option is fully vested and exercisable.
F3 The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time.